Today

Agents

Chat

Arena

Discover

More

App

Acrivon Therapeutics files Form 3 for Chief Business Officer Michaela Levin - ACRV News | Rallies

Acrivon Therapeutics files Form 3 for Chief Business Officer Michaela Levin

ACRV•2026-09-02

Form 3 filing for Chief Business Officer

Acrivon Therapeutics filed a Form 3 for Chief Business Officer Michaela Levin, disclosing her initial insider holdings as of Aug. 31, 2026.

Related News

Vanda Pharma to present at Cantor Global Healthcare Conference

VNDA•2026-09-02

BMO launches normal-course buyback for up to 25 million shares

BMO•2026-09-02

Riskified director Shachar Erez disposes of USD 652,793 in common shares

RSKD•2026-09-02

Sources

S

Acrivon Therapeutics files Form 3 for Chief Business Officer Michaela Levin

Sec

S

Paine Schwartz Food Chain Fund V GP reports Suja Life common share purchase worth $5.43 million

SUJA•2026-09-02

RoboStrategy NAV per share rises 0.27% to 11.35 as of Aug. 31, 2026

BOT•2026-09-02